Castleark Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-245,798
Closed -$21.3M 374
2019
Q4
$21.3M Sell
245,798
-8,269
-3% -$679K 0.85% 33
2019
Q3
$20.4M Sell
254,067
-295,268
-54% -$23.7M 0.83% 27
2019
Q2
$44M Sell
549,335
-9,625
-2% -$737K 1.69% 5
2019
Q1
$44.4M Buy
558,960
+239,852
+75% +$17.9M 1.67% 6
2018
Q4
$23.3M Buy
+319,108
New +$22.5M 0.99% 25
2015
Q3
Sell
-374,450
Closed -$20.3M 391
2015
Q2
$20.3M Sell
374,450
-216,046
-37% -$12.1M 0.54% 46
2015
Q1
$32.4M Buy
590,496
+279,785
+90% +$15.8M 0.78% 33
2014
Q4
$16.8M Buy
+310,711
New +$17.3M 0.43% 55
2013
Q4
Sell
-255,628
Closed -$14.5M 358
2013
Q3
$14.5M Buy
+255,628
New +$11.7M 0.41% 51

Other funds holding MRK

Castleark Management's MRK Position: Q1 2020 in Review

Castleark Management sold out of Merck (MRK) in Q1 2020, closing a stake of 245,798 shares — an estimated $21.3M sold.

Castleark Management first reported a position in MRK in Q3 2013 and held it in 9 quarters. The position peaked at $44.4M in Q1 2019. 2,478 funds tracked by Wall St. Rank hold MRK as of Q1 2020.

  • Castleark Management reported no remaining Merck position as of Q1 2020 after selling out during the quarter.
  • Castleark Management sold 245,798 Merck shares in Q1 2020, an estimated $21.3M.
  • Castleark Management first reported a position in Merck in Q3 2013 and held it in 9 quarters.
  • Castleark Management's Merck position peaked at $44.4M in Q1 2019.
  • 2,478 funds tracked by Wall St. Rank held Merck as of Q1 2020.

Based on Castleark Management's 13F filing for Q1 2020, filed 13 May 2020.